NCT02386800 2026-03-16CINC424A2X01B Rollover ProtocolNovartisPhase 4 Active not recruiting279 enrolled
NCT03229200 2025-10-30Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.Pharmacyclics Switzerland GmbHPhase 4 Active not recruiting297 enrolled
NCT01856803 2020-09-25Anti-thymocyte Globulins for Graft-versus-host Disease ProphylaxisPeking University People's HospitalPhase 4 Completed300 enrolled
NCT00003398 2019-10-17Bone Marrow Transplantation in Treating Patients With Hematologic CancerUniversity of Maryland, BaltimorePhase 4 Completed45 enrolled